In mammals, STAU1 mediates embryonic stem cell differentiation 1 , mRNA transport and localization 2,3 , mRNA translational activation 4 , HIV type 1 assembly 5, 6 and SMD [7] [8] [9] [10] . During SMD, STAU1 triggers the translation-dependent degradation of specific mRNAs that contain a STAU1-binding site (SBS) within their 3′ untranslated region (3′ UTR) to regulate gene expression during myogenesis 7 , keratinocyte motility 10 , adipogenesis 11 and probably other mammalian cellular pathways. In human cells, SBSs can be created in cis by intramolecular base pairing within an mRNA 3′ UTR 9 or in trans by base pairing between partially complementary Alu elements within an mRNA 3′ UTR and a long noncoding RNA 10 . When translation terminates sufficiently upstream of an SBS so as not to disrupt the SBS, association of the UPF1 RNA helicase with SBS-bound STAU1 triggers mRNA decay (reviewed in ref. 12).
RESULTS

Vertebrate STAU has a conserved motif N-terminal to 'RBD'5
Using yeast two-hybrid analyses, a recent study 25 demonstrated that full-length hSTAU1 55 interacts with residues 408-496 of another hSTAU1 55 molecule. These amino acids consist of the C terminus of hSTAU1 55 and include 'RBD'5 ( Fig. 1a and Supplementary Fig. 1a ), which has only 18% sequence identity to the prototypical hSTAU1 RBD3 and does not bind dsRNA 15, 17 . Multiple sequence alignments, carried out using ClustalW 26 , of full-length hSTAU1 with hSTAU2 and STAU orthologs from representatives of the five major vertebrate classes revealed a conserved sequence residing N-terminal to 'RBD'5 that consists of hSTAU1 55 residues 371-390 (Supplementary Fig. 1a) . We named this motif the SSM (Fig. 1a and Supplementary Fig. 1a ) for reasons explained below. Despite an identifiable 'RBD'5, an SSM is absent from, for example, D. melanogaster and Caenorhabditis elegans STAU proteins ( Supplementary Fig. 1b) . However, STAU proteins in other invertebrates contain both SSM and 'RBD'5 regions (Supplementary Fig. 1b) . The SSM is proximal to the TBD, which spans residues 282-372 (ref. 15) (Fig. 1a) , and it overlaps with residues 272-405, at least part of which recruits hUPF1 during SMD 7 .
Structure of hSTAU1 SSM-'RBD'5
A search of the NCBI Conserved Domain Database 27 did not identify hSTAU1 'RBD'5 as an RBD. To understand the atomic details of SSM-'RBD'5, we purified hSTAU1 residues 367-476 from Escherichia coli (Supplementary Fig. 2a ), produced crystals that we verified were intact using SDS-PAGE and silver staining (Supplementary Fig. 2a) , and solved its X-ray crystal structure at 1.7 Å ( Table 1) . Our structure revealed that 'RBD'5 adopts the α-β-β-β-α topology of a prototypical RBD, and the SSM forms two α-helices (hereafter called SSM α1 and α2) that are connected by a tight turn (Fig. 1b and 55 . Relative positions are indicated for the true RBDs RBD3 and RBD4, degenerate 'RBD'2, the TBD in vitro (residues 282-372) and the SSM-'RBD'5 region (residues 367-476). The secondary structure of hSTAU1 55 (blue) derives from data reported here, and the dashed line denotes residues 397-402 that are missing from the crystal structure. (b) X-ray crystal structure shown as a single hSTAU1 55 SSM-'RBD'5 molecule (left, blue) and a domainswapped dimer formed with another molecule in the crystal lattice (right, green). Asterisks denote alternative conformations of the linker ( Supplementary Fig. 2c ). Connectivities between an SSM and 'RBD'5 that could not be modeled because of multiple conformations and/or disorder in the crystal structure are indicated by dotted lines. Structural elements are also identified. (c) Close-up view of the interaction between the SSM α-helices (green, α1 and α2) and the 'RBD'5 α-helices (blue, α1 and α2). Important residues are shown as stick representations and are labeled. Residues that contribute to the hydrophobic core are yellow. Hydrogen bonds between polar atoms are shown as dashed lines. (d) Polar interactions between SSM Arg376 and 'RBD'5 main chain oxygens; the SSM is green, 'RBD'5 is blue, and key residues and the citrate ion ligand (orange) are shown as sticks and are labeled. Hydrogen bonds are shown as dashed lines. npg a r t i c l e s Supplementary Fig. 2b ). Electron density was clearly interpretable for the SSM and 'RBD'5 but not for residues 397-402, which form part of the linker (residues 393-406) between the SSM and 'RBD'5 (Fig. 1a,b and Supplementary Fig. 1a) . We observed two conformations at the C-terminal, or 'RBD'5, side of the linker, each hinged at Leu405 so that the position of Pro404 was variable (Supplementary Fig. 2c ). The observed variability raises the possibility that the SSM may interact with 'RBD'5 as a monomer (cis), dimer (trans) or both in the crystal structure (Fig. 1b) , but we cannot correlate either linker conformation with a monomeric or dimeric state. Each 649-Å 2 interface is created when the 'V' shape formed by SSM α1 and α2 straddles 'RBD'5 α1, whereas the V shape created by 'RBD'5 α1 and α2 straddles SSM α1 (Fig. 1b-d) .
The interactions of an SSM and an 'RBD'5 form a core composed of residues with hydrophobic side chains (Fig. 1c) . The external solvent boundary of this core is defined by Thr371 of the longer of the two SSM α-helices, α1; Ser384 of SSM α2; Gln411, Tyr414 and Gln419 of 'RBD'5 α1; and Lys470 of 'RBD'5 α2 (Fig. 1c) . Each of these residues amphipathically contributes hydrophobic portions of their side chains to the core, with their polar component pointed outward. Val370, Ile374, Ala375, Leu378 and Leu379 of SSM α1 also contribute to the hydrophobic core, as do Ala387, Ile390 and Leu391 of SSM α2; 'RBD'5 α1 constituents Pro408 (which starts α1), Leu412, Leu415 and Val418; and Phe421 of loop 1 (L1) (Fig. 1c) . Additionally, 'RBD'5 α2 contributes Leu466, Leu469, Leu472 and Leu475 (Fig. 1c) . 
npg a r t i c l e s
Of the two polar interactions at the SSM-'RBD'5 interface, one is a basic charge contributed by SSM Arg376: its two η-amine groups hydrogen bond with two carboxyl groups of the citrate anion present in the crystal structure, and its η-and ε-amines interact with the main chain oxygens of Glu474 and Ser473, respectively, which are positioned near the C terminus of 'RBD'5 α2 (Fig. 1d) . SSM Arg376 is conserved in all vertebrates analyzed except Danio rerio, in which the residue is asparagine, and Glu474 and Ser473 are invariant in vertebrates that contain the 'RBD'5 α2 C terminus ( Supplementary  Fig. 1a) . In the other polar interaction, the side chain hydroxyl group of SSM Thr371 and the main chain oxygen of Lys367 hydrogen bond with the amine group of 'RBD'5 Gln419, and the ε-amine of Lys367 hydrogen bonds with the hydroxyl group of Gln419 (Fig. 1c) . SSM residues lacking strict conservation (Met373, Tyr380, Gly381, Thr383 and Pro385) are positioned on the solvent-exposed side, opposite the interface that interacts with 'RBD'5 ( Supplementary Fig. 2d ).
Comparison of 'RBD'5 to an RBD that binds dsRNA We were surprised that the three RBD structures identified by the Dali server 28 as the most structurally similar to 'RBD'5 bind dsRNA (Supplementary Table 1 ). Of the three, Aquifex aeolicus RNase III RBD 29 provides the most complete comparison. A structure-based sequence alignment of this RBD with hSTAU1 'RBD'5 revealed that although the two structures are nearly identical, hSTAU1 'RBD'5 has a slightly shorter L1, an altered L2 and a longer L3 (Fig. 2a,b) . Furthermore, hSTAU1 'RBD'5 lacks key residues that typify the three RNA-binding regions (regions 1, 2 and 3) of canonical RBDs 23 and are present in the A. aeolicus RNase III RBD (Fig. 2b) . The clearest differences are in regions 2 (within L2) and 3. hSTAU1 'RBD'5 L2, which does not extend as far as A. aeolicus RNase III RBD L2 (Fig. 2a) and thus may be unable to reach the minor groove of dsRNA, lacks a histidine residue that interacts with the dsRNA minor groove in the A. aeolicus RNase III RBD 29 and true RBDs 23 (Fig. 2c) . The importance of an L2 histidine residue derives from studies of D. melanogaster STAU RBD3 (Supplementary Fig. 3a) , in which RNA binding was lost when the sole L2 histidine was changed to alanine 22 . With regard to region 3, the positively charged residues in the A. aeolicus RNase III RBD that interact with the negatively charged phosphate backbone spanning the dsRNA major groove are negatively charged in hSTAU1 'RBD'5 and might actually repel dsRNA (Figs. 2b- Fig. 3a,b) .
Human SSM-'RBD'5 homodimerizes in solution and in cells
Our crystal structure analyses raised the possibility that the SSM could mediate hSTAU1 dimerization by trans interactions with 'RBD'5. Thus, we tested whether SSM-'RBD'5 is sufficient to mediate dimerization of hSTAU1. After purifying glutathione S-transferase-tagged SSM-'RBD'5 (GST-SSM-'RBD'5) from E. coli and removing the GST tag, we found that SSM-'RBD'5 migrated at the size of a dimer during gel filtration (Fig. 3a) . Sedimentation velocity determinations using analytical ultracentrifugation confirmed that the average weight distribution of SSM-'RBD'5 shifted to lower Svedberg values at lower concentrations (Fig. 3b) . The best-fit model for SSM-'RBD'5 derived from the three highest concentrations tested (0.0090 mg ml −1 root mean s.d. (r.m.s. deviation) fit to the model) was one of rapid monomer (1.32 +0.02/-0.03 S)-dimer (2.21 ± 0.01 S) equilibrium, where the dimer K d was 79 ± 9 µM. That purified SSM-'RBD'5 assumes a dimeric solution state supports the existence of a trans, swapped interaction between the SSM of one hSTAU1 molecule and the 'RBD'5 of another.
To determine whether the SSM mediates dimerization of full-length hSTAU1 in vivo, we transiently transfected human embryonic kidney 293T (HEK293T) cells with a mixture of two plasmids: (i) peGFP-'RBD'5, which produces monomeric enhanced GFP (eGFP)-tagged 'RBD'5, and either pmRFP-SSM-'RBD'5 or pmRFP-'RBD'5, which produce monomeric red fluorescence protein (mRFP)-tagged SSM-'RBD'5 or mRFP-'RBD'5, respectively; or (ii) peGFP-SSM-'RBD'5 and either pmRFP-SSM-'RBD'5 or pmRFP-'RBD'5 ( Supplementary  Fig. 4a ). The results of immunoprecipitations in the presence of RNase A using anti-GFP or, as a negative control, mouse IgG (mIgG) revealed that dimerization cannot occur between two 'RBD'5 molecules but can occur if one of the two 'RBD'5 molecules contributes an SSM ( Supplementary Fig. 4a,b ; see Supplementary Note 1 for extended details and Supplementary Table 2 for immunoprecipitation and coimmunoprecipitation efficiencies).
To exclude the possibility that linker residues 393-406 contribute to the interaction between the SSM of one hSTAU1 molecule and 'RBD'5 of another, we tested whether eGFP-SSM interacts with mRFP-'RBD'5. We transiently transfected HEK293T cells with a mixture of two plasmids: one that produces eGFP-SSM and a second that produces mRFP-SSM-'RBD'5, mRFP-'RBD'5 or, as a negative control, mRFP (Fig. 4a) . We then generated cell lysates and analyzed them in the presence of RNase A before and after immunoprecipitation using anti-GFP or mIgG.
Each mRFP-tagged protein and mRFP alone were expressed at comparable levels ( Fig. 4b) , and anti-GFP immunoprecipitated comparable amounts of eGFP-SSM (Fig. 4b) . Although eGFP-SSM npg a r t i c l e s did not coimmunoprecipitate with mRFP, it did coimmunoprecipitate with mRFP-SSM-'RBD'5 and mRFP-'RBD'5 with comparable efficiencies, indicating that the linker does not substantially contribute to the interaction of the SSM and 'RBD'5 when each derives from a distinct molecule (Fig. 4b) . eGFP-SSM also coimmunoprecipitated with cellular hSTAU1 isoforms but not with cellular hUPF1 (Fig. 4b) .
Disrupting hSTAU1 dimerization inhibits UPF1 binding and SMD
We next expressed mRFP-'RBD'5 with the goal of inhibiting hSTAU1 dimerization. To this end, we transiently transfected HEK293T cells with short interfering RNA (siRNA)-resistant (R) plasmids, producing Flag-tagged hSTAU1 55(R) (hSTAU1 55(R) -Flag), hSTAU1 55 tagged with three hemagglutinin moieties in tandem (hSTAU1 55 -HA 3 ) and either mRFP-'RBD'5 or, as a negative control, mRFP. We then generated cell lysates and analyzed them in the presence of RNase A before and after immunoprecipitation using anti-Flag or, as a negative control, mIgG. Comparable amounts of hSTAU1 55(R) -Flag were expressed and immunoprecipitated using anti-Flag in the presence of a comparable amount of either mRFP or mRFP-'RBD'5 ( Fig. 4c) . Furthermore, hSTAU1 55(R) -Flag and hSTAU1 55 -HA 3 were not overexpressed relative to cellular hSTAU1 55 (Supplementary Fig. 4c ). mRFP-'RBD'5 expression reduced the amount of hSTAU1 55 -HA 3 that coimmunoprecipitated with hSTAU1 55(R) -Flag to 35-40% of the amount that coimmunoprecipitated in the presence of mRFP alone (Fig. 4c) . Our finding that mRFP-'RBD'5 expression also reduced the amount of cellular hUPF1 that coimmunoprecipitated with hSTAU1 55(R) -Flag to 35-40% of the amount that coimmunoprecipitated in the presence of mRFP alone (Fig. 4c) , together with the finding that 'RBD'5 does not (Fig. 4b) 7 , indicates that hUPF1 binds hSTAU1 dimers more efficiently than hSTAU1 monomers. We additionally examined the effect of mRFP-'RBD'5 or eGFP-SSM, which we predicted would also inhibit hSTAU1 dimerization, on the efficiency of SMD by assaying the HEK293T SMD targets SOWAHC (formerly called FLJ21870 in refs. 7,10) mRNA, GAP43 mRNA and c-JUN (JUN) mRNA 7, 9 . Each tagged protein was expressed in HEK293T cells comparably to its corresponding tag-only control (Fig. 4d) . Transfections using plasmids expressing eGFP-SSM or mRFP-'RBD'5 increased the abundance of each SMD target 2-to 2.5-fold relative to transfections using an empty vector (pcI-neo) or a plasmid expressing eGFP or mRFP, respectively, none of which affected SMD target abundance ( Fig. 4d and Supplementary Fig. 4d) . Thus, hSTAU1 dimerization is crucial for efficient SMD because dimerization augments hSTAU1 binding to hUPF1.
To define the minimal segment necessary for hSTAU1 dimerization in vivo, we transiently transfected HEK293T cells with pcI-neo-hSTAU1 55 -HA 3 and one of three siRNA-resistant plasmids that produce hSTAU1 55(R) WT-Flag, hSTAU1 55(R) (C-term)-Flag (with deletion of residues C-terminal to the first α-helix of 'RBD'5) or hSTAU1 55(R) ∆(SSM-'RBD'5)-Flag (with deletion of the entire SSM-'RBD'5 region), hereafter called WT, ∆(C-term) and ∆(SSM-'RBD'5), respectively (Fig. 5a) . We generated cell lysates and analyzed them in the presence of RNase A before and after immunoprecipitation using anti-Flag or, as a negative control, mIgG, or anti-HA or, as a negative control, rat IgG (rIgG).
The three Flag-tagged proteins were expressed at comparable levels before immunoprecipitation relative to each other (Fig. 5b) and relative to cellular hSTAU1 55 (Supplementary Fig. 5a ) and were immunoprecipitated with comparable efficiencies using anti-Flag (Fig. 5b) . The level at which hSTAU1 55 -HA 3 or cellular hUPF1 coimmunoprecipitated with ∆(SSM-'RBD'5) was only ~10% of the level at which hSTAU1 55 -HA 3 or cellular hUPF1 coimmunoprecipitated with either WT or ∆(C-term) (Fig. 5b) . Immunoprecipitations of the same transfections Supplementary Fig. 5a ), where black symbols denote a hSTAU1 band (c), and histogram of the RT-PCR analyses (d; Supplementary Fig. 5e ) of HEK293T cells (1 × 10 7 ) that had been transiently transfected with the specified siRNA (100 nM) and, 2 d later, with the specified siRNA-resistant hSTAU1 55(R) -Flag expression vector or pcI-neo (1 µg), a pFLUC-SMD reporter construct (3 µg) and the pRLUC reference plasmid (3 µg). For the histograms, the level of each mRNA indicated at right was normalized to the level of RLUC (for FLUC-SMD reporter mRNAs) or GAPDH mRNA (for cellular mRNAs), and normalized levels are shown as a percentage of the normalized level in the presence of control siRNA, which was defined as 100. Results are representative of three independently performed experiments. Error bars, s.e.m. *P < 0.05 determined using one-tailed t-test.
a r t i c l e s using either anti-HA or, as a negative control, rIgG revealed that the level at which ∆(SSM-'RBD'5) coimmunoprecipitated with hSTAU1 55 -HA 3 was only ~10% the level at which WT or ∆(C-term) coimmunoprecipitated with hSTAU1 55 -HA 3 ( Supplementary  Fig. 5b) . Thus, domain swapping between SSM and 'RBD'5 is the major determinant of hSTAU1 dimerization and can be achieved even when one of the interacting proteins lacks residues C-terminal to 'RBD'5 α1. Consistent with this conclusion, assays of the three detectable cellular hSTAU2 isoforms demonstrated that hSTAU2 coimmunoprecipitated with each hSTAU1 55(R) -Flag variant with the same relative efficiency as did hSTAU1 55 -HA 3 (Fig. 5b) . Thus, hSTAU1 can homodimerize or heterodimerize with hSTAU2. 
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Using anti-Flag to immunoprecipitate a hSTAU1 55(R) -Flag variant or anti-HA to immunoprecipitate hSTAU1 55 -HA 3 , the coimmunoprecipitation of hUPF1 correlated with homodimerization ability (Fig. 5b and Supplementary Fig. 5b ), which is in agreement with data obtained using mRFP-'RBD'5 to disrupt dimerization (Fig. 4c) . However, homodimerization did not augment the binding of hSTAU1 55 to an SBS because SOWAHC mRNA and c-JUN mRNA each coimmunoprecipitated with WT, ∆(C-term) and ∆(SSM-'RBD'5) to the same extent (Supplementary Fig. 5c ).
As ∆(SSM-'RBD'5) has residual dimerization activity (10% that of WT), and in view of reports that hSTAU1 'RBD'2 residues 37-79 interact with full-length hSTAU1 55 (ref. 25) , we assayed the ability of E. coli-produced hSTAU1-'RBD'2-RBD3 (residues 43-173) to dimerize. Gel filtration demonstrated that hSTAU1-'RBD'2-RBD3 indeed migrates at the position expected of an 'RBD'2-RBD3−'RBD'2-RBD3 dimer (Supplementary Fig. 5d) . The low level of residual activity suggests that the contribution of 'RBD'2 to hSTAU1 dimerization is relatively minor and, as such, we did not pursue it further.
Inhibiting hSTAU1 dimerization should inhibit SMD on the basis of our finding that dimerization promotes the association of hSTAU1 with hUPF1. To test this hypothesis, we transiently transfected HEK293T cells with: (i) STAU1(A) siRNA 8 ; (ii) a plasmid expressing one of the three hSTAU1 55(R) -Flag variants or, as a control, no protein; (iii) three plasmids that produce a firefly luciferase (FLUC) reporter mRNA, namely, FLUC-No SBS mRNA 8 , which lacks an SBS, FLUChARF1 SBS mRNA 8 , which contains the hARF1 SBS, and FLUChSERPINE1 3′ UTR mRNA 9 , which contains the hSERPINE1 SBS; and (iv) a reference plasmid that produces Renilla luciferase (RLUC) mRNA. In parallel, we transfected cells with (i) control siRNA 7 , (ii) a plasmid producing no hSTAU1 55(R) -Flag protein, (iii) the three FLUC reporter plasmids and (iv) the RLUC reference plasmid.
STAU1(A) siRNA reduced the abundance of cellular hSTAU1 to ~10% of that in control siRNA-treated cells, and each hSTAU1 55(R) -Flag variant was expressed at a comparable abundance that approximated that of cellular hSTAU1 55 (Fig. 5c) . After normalizing the level of each FLUC mRNA to the level of RLUC mRNA, we found the normalized level of FLUC-No SBS mRNA, which is not an SMD target, to be essentially identical in all transfections ( Fig. 5d and Supplementary  Fig. 5e ). In contrast, the normalized levels of FLUC-hARF1 SBS mRNA and FLUC-hSERPINE1 3′ UTR mRNA were increased approximately two-fold in the presence of STAU1(A) siRNA alone, as were the normalized levels of SOWAHC, GAP43 and c-JUN mRNAs, consistent with an inhibition of SMD (Fig. 5d) . This inhibition was reversed by 50% when WT or ∆(C-term) was expressed but not when ∆(SSM-'RBD'5) was expressed (Fig. 5d) . Thus, WT and ∆(C-term) can functionally compensate for the siRNA-mediated downregulation of cellular hSTAU1 more efficiently than can ∆(SSM-'RBD'5). These data indicate that hSTAU1 dimerization is important for SMD.
To define specific amino acids of hSTAU1 that contribute to domain swapping, we used our X-ray crystal structure to design seven variants of hSTAU1 55(R) -Flag that, relative to the deletion-bearing variants, would harbor more subtle changes ( Fig. 5a and Supplementary  Fig. 6a ). We designed mutations to target the SSM−'RBD'5 interface and minimize any effects on the overlapping intramolecular hydrophobic interactions within 'RBD'5 itself. When subjected to secondary structure predictions using PsiPred 30, 31 , none of the mutations was predicted to disrupt the α-helical structure within which each resides.
Of the seven variants, only hSTAU1 55(R) -Flag harboring A375E, R376A, L472S and S473E (called hereafter Mut #7) disrupted hSTAU1 55(R) -Flag dimerization with hSTAU1 55 -HA 3 ( Supplementary  Fig. 6b) . This variant contains a bulky substitution at residue 375, a change at residue 376 that disrupts one of the two polar interactions in the hSTAU1 SSM-'RBD'5 interface and L472S and S473E, both of which target residues within 'RBD'5 α2 that interact with SSM α1 (Fig. 1c,d) . Notably, T371R and Q419A, which disrupt the second polar interaction in the hSTAU1 SSM-'RBD'5 interface, do not affect dimerization either individually or when combined in cis (Supplementary Fig. 6b) .
Western blotting of lysates of HEK293T cells that transiently expressed comparable amounts of Mut #7 and hSTAU1 55 -HA 3 ( Fig. 6a  and Supplementary Fig. 6c ) at levels that approximated that of cellular hSTAU1 55 (Supplementary Fig. 6b ) revealed that hSTAU1 55 -HA 3 , cellular hUPF1 and isoforms of cellular hSTAU2 did not coimmunoprecipitate efficiently with Mut #7 (Fig. 6a and Supplementary  Fig. 6c) . Also, the binding of Mut #7 to the SMD targets SOWAHC and c-JUN mRNAs was not compromised (Supplementary Fig. 6d) . Consistent with the importance of hSTAU1 dimerization to SMD, Mut #7 was less able to reverse the STAU1(A) siRNA-mediated inhibition of SMD than was WT (Fig. 6b,c) .
Disrupting STAU1 dimerization inhibits wound healing
Downregulating the levels of SERPINE1 and RAB11FIP1 mRNAs, which are SMD targets, increases keratinocyte motility in a scrape injury-repair (wound-healing) assay 10 . To test the physiological importance of disrupting hSTAU1 dimerization, we expressed WT, ∆(C-term), ∆(SSM-'RBD'5) and Mut #7 individually at equal levels in human HaCaT keratinocytes that had been treated with STAU1(A) siRNA, which reduced the cellular hSTAU1 abundance to 10% of that in control siRNA-treated cells ( Fig. 6d ; pcI-neo served as a control). After 16 h, enhanced keratinocyte motility was evident in the presence of STAU1 siRNA alone, consistent with SERPINE1 and RAB11FIP1 proteins enhancing wound healing 10 , and also when cellular hSTAU1 was replaced by ∆(SSM-'RBD'5) or Mut #7, neither of which can dimerize to mediate SMD (Fig. 6e) . On the basis of these findings and data showing that replacing cellular hSTAU1 with either WT or ∆(C-term), each of which supports hSTAU1 dimerization, had no effect on keratinocyte motility (Fig. 6e) , we conclude that contributions of hSTAU1 dimerization to the efficiency of SMD are indeed important in promoting wound healing.
DISCUSSION hSTAU1 homodimerization requires a previously unknown motif
Here we describe the hSTAU1 SSM, which is a two-helix motif (Fig. 1) that interacts with dsRNA binding-deficient 'RBD'5 of another hSTAU1 molecule (Figs. 1,3-6 and Supplementary Figs. 2 and 4-6) . We propose that the SSM is a modular adaptation in many, and possibly all, vertebrate STAU homologs that mediates STAU dimerization through its interaction with 'RBD'5. Although the connectivity between the SSM and 'RBD'5 cannot be modeled, we suggest that the dynamic nature of the linker (Supplementary Fig. 2c ) allows hSTAU1 SSM-'RBD'5 to exist in both monomeric and dimeric states, and both states potentially exist in the crystal structure. We support our crystallographic model for dimerization by demonstrating that hSTAU1 SSM-'RBD'5 dimers form in solution in vitro (Fig. 3) and in cells (Figs. 4-6 and Supplementary Figs. 4-6) . If hSTAU1 multimerization were to occur in cells, it would probably involve not only SSM interacting with 'RBD'5 in trans (Fig. 4) but also weaker contributions from 'RBD'2 (ref. 25 and Supplementary Fig. 5 ). Possibly, dimerization through intermolecular 'RBD'2-'RBD'2 interactions would promote trans over cis interactions between SSM and 'RBD '5. Data indicate that the minimal region of 'RBD'5 from one molecule that is needed to interact with the SSM from another is 'RBD'5 α1. npg a r t i c l e s First, sequences that reside C-terminal to 'RBD'5 α1 are not required for hSTAU1-hSTAU1 dimerization (Fig. 5) . Second, the smallest hSTAU2 isoform coimmunoprecipitates with hSTAU1 55 even though its 'RBD'5 consists of only α1 and L1 (Fig. 5 and Supplementary  Fig. 1 ). Thus, all STAU1 isoforms can dimerize, if not multimerize, with themselves and/or all STAU2 isoforms. We suggest that 'RBD'5 α2 may stabilize dimer formation given that the SSM-'RBD'5 interaction can be disrupted by simultaneously mutating both SSM and 'RBD'5 α2 (Fig. 6) . Additionally, mutations at the SSM-'RBD'5 α1 interface do not effectively disrupt dimerization, possibly because of the compensating presence of 'RBD'5 α2 (Supplementary Fig. 6 ).
hSTAU1 homodimerization contributes to SMD Compared to hSTAU1 monomers, hSTAU1 dimers bind hUPF1 more efficiently (and mediate SMD more effectively) without promoting dsRNA binding (Figs. 4-6 and Supplementary Figs. 4-6) . Thus, cells may regulate SMD by controlling hSTAU1 abundance 32 and, therefore, dimer formation (Fig. 7) . There is clear evidence that multiple hSTAU1 55 molecules can bind a single dsRNA. For example, multiple hSTAU1 55 molecules bind the hARF1 SMD target in cells 25 and mRNAs containing as many as 250 CUG repeats that typify patients with myotonic dystrophy in vitro 33 . Also, our finding that hSTAU1 55 stabilizes the relatively large (86-298 imperfectly basepaired) regions that constitute intermolecular SBSs formed between an mRNA and a long noncoding RNA through Alu-element base pairing 10 suggests that multiple hSTAU1 molecules bind in tandem to the same dsRNA to efficiently recruit the ATP-dependent helicase hUPF1. Proteins known to dimerize and become activated on double-stranded nucleic acids are exemplified by transcriptional activators (for review, see ref. 34 ), the adenosine deaminases ADAR1 and ADAR2 (refs. 35,36) , and the protein kinase PKR (for review see ref. 37 ).
hSTAU1 'RBD'5 has functionally diverged from a true RBD Assuming hSTAU1 'RBD'5 evolved from a functional RBD, it not only lost the ability to bind dsRNA but gained the ability to interact with the SSM. Whereas regions 2 and 3 of true RBDs interact with the minor groove and bridge the proximal major groove of dsRNA, respectively 23 , these regions in 'RBD'5 are mutated so as to be incapable of these functions (Fig. 2) . Furthermore, in contrast to region 1 of true RBDs, which determines RNA recognition specificity by binding the minor groove and, possibly, distinguishing features such as loops at the apex of dsRNA 22, 24 , region 1 of 'RBD'5 specifies SSM recognition (Fig. 1) . Notably, 'RBD'5 region 1 interacts with the SSM using a face that is orthogonal to the face that would interact with dsRNA in a true RBD.
The RBD fold as a template for functional diversity As reported here, the combination of a modified RBD (hSTAU1 'RBD'5) within the context of an adaptor region (hSTAU1 SSM) can promote greater functionality within the larger, often modular and flexible framework of RBD-containing proteins. In support of this view, modifications that consist of an L1 cysteine and an L3 histidine within the RBD of the Schizosaccharomyces pombe Dicer DCR1 protein work together with a 33-residue region that resides C-terminal to the RBD to form a zinc-coordination motif that is required for nuclear retention and, possibly, dsDNA binding 38 .
'RBD's that do not bind dsRNA may also acquire new functions independently of adjacent regions. For example, 'RBD'5 of D. melanogaster STAU has adapted to bind the Miranda protein that is required for proper localization of prospero mRNA 39, 40 . In addition, human TAR RNA-binding protein 2 contains three RBDs, the most C-terminal of which binds Dicer instead of dsRNA 41, 42 . Furthermore, 'RBD'3 of Xenopus laevis RNA-binding protein A, similarly to its human homolog p53-associated cellular protein, seems to homodimerize independent of an accessory region 43 . It will be interesting to determine whether hSTAU1 'RBD'2-mediated dimerization 25 involves an adaptor motif or occurs solely through the RBD fold.
METHODS
Methods and any associated references are available in the online version of the paper. Figure 7 Model for how hSTAU1 dimers recruit hUPF1 to the 3′ UTR of an mRNA that is targeted for SMD and promote its decay. hSTAU1 can bind to an SBS as a dimer or a monomer, most likely depending on the length of the SBS and hSTAU1 concentration. Shown here is an intermolecular SBS formed by base pairing of an mRNA 3′ UTR (top) with a long noncoding RNA (bottom). SBSs can also form through intramolecular base pairing 32 within an mRNA 3′ UTR. Dimerization is mediated by reciprocal domain-swapped interactions between the SSM of one hSTAU1 molecule (blue) and the 'RBD'5 of another (green). Note that 'RBD'2 may also facilitate hSTAU1-hSTAU1 dimerization 25 , which could change the orientation of the hSTAU1 dimer from what is shown here. hSTAU1 dimerization promotes hUPF1 binding. Binding activates UPF1 helicase activity and initiates mRNA decay 20 
